Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure

被引：0
作者：
Riccardo M. Inciardi
Alessandro Mantovani
Giovanni Targher
机构：
[1] University of Brescia,ASST Spedali Civili Di Brescia, Division of Cardiology and Department of Medical and Surgical Specialties, Radiological Sciences and Public Health
[2] University of Verona,Department of Medicine, Section of Endocrinology, Diabetes, and Metabolism
来源：
Current Heart Failure Reports | 2023年 / 20卷
关键词：
NAFLD; Non-alcoholic fatty liver disease; Heart failure; Metabolic dysfunction-associated fatty liver disease; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：308 / 319
页数：11
相关论文
共 377 条
  • [1] McDonagh TA(2021)2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Eur Heart J 42 3599-3726
  • [2] Metra M(2023)The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review Hepatology 77 1335-1347
  • [3] Adamo M(2020)Complications, morbidity and mortality of nonalcoholic fatty liver disease Metabolism 111S 154170-116
  • [4] Gardner RS(2022)The EASL-lancet liver commission: protecting the next generation of Europeans against liver disease complications and premature mortality Lancet 399 61-913
  • [5] Baumbach A(2021)Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis Lancet Gastroenterol Hepatol 6 903-e185
  • [6] Bohm M(2022)Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart association Arterioscler Thromb Vasc Biol 42 e168-439
  • [7] Younossi ZM(2018)Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease Nat Rev Gastroenterol Hepatol 15 425-946
  • [8] Golabi P(2022)Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis Eur J Prev Cardiol 29 938-956
  • [9] Paik JM(2022)Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world Aliment Pharmacol Ther 56 942-801
  • [10] Henry A(2023)AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease Hepatology 71 793-30
12345678910